Table 2.
All NHL |
FL |
||||||||
---|---|---|---|---|---|---|---|---|---|
Variable, level | Cut point Value |
Controls | Cases | Odds Ratio* |
95% CI | Cases | Odds Ratio* |
95% CI | |
Recent Adult BMI (2 years prior to case diagnosis / control enrollment) | |||||||||
<18.5 | 13 | 8 | 0.85 | 0.34–2.09 | 3 | 1.08 | 0.30–3.89 | ||
18.5–24.9 | 353 | 276 | 1 | Reference | 80 | 1 | Reference | ||
25.0–29.9 | 466 | 378 | 0.96 | 0.78–1.18 | 85 | 0.75 | 0.54–1.06 | ||
30.0+ | 286 | 273 | 1.15 | 0.91–1.45 | 73 | 1.07 | 0.75–1.52 | ||
P-trend | 0.23 | 0.84 | |||||||
males | 18.5–24.9 | 118 | 115 | 1 | Reference | 29 | 1 | Reference | |
25.0–29.9 | 302 | 254 | 0.87 | 0.64–1.18 | 56 | 0.75 | 0.46–1.24 | ||
30.0+ | 174 | 174 | 1.03 | 0.74–1.44 | 38 | 0.89 | 0.52–1.52 | ||
P-trend | 0.73 | 0.75 | |||||||
females | <18.5 | 13 | 8 | 0.89 | 0.36–2.23 | 3 | 1.06 | 0.29–3.90 | |
18.5–24.9 | 235 | 161 | 1 | Reference | 51 | 1 | Reference | ||
25.0–29.9 | 164 | 124 | 1.05 | 0.77–1.43 | 29 | 0.76 | 0.46–1.26 | ||
30.0+ | 112 | 99 | 1.27 | 0.90–1.78 | 35 | 1.41 | 0.86–2.30 | ||
P-trend | 0.17 | 0.31 | |||||||
P-interaction+ | 0.53 | 0.37 | |||||||
Early Adult BMI (at age 18) | |||||||||
Quartile 1 | 289 | 214 | 1 | Reference | 63 | 1 | Reference | ||
Quartile 2 |
Uses gender specific cut- points below |
282 | 188 | 0.88 | 0.68–1.14 | 49 | 0.79 | 0.53–1.20 | |
Quartile 3 | 275 | 245 | 1.2 | 0.94–1.54 | 56 | 0.95 | 0.64–1.41 | ||
Quartile 4 | 282 | 287 | 1.38 | 1.08–1.76 | 72 | 1.18 | 0.81–1.73 | ||
P-trend | 0.0012 | 0.27 | |||||||
males | Quartile 1 | <=20.94 | 157 | 145 | 1 | Reference | 41 | 1 | Reference |
Quartile 2 | 20.95–22.49 | 145 | 100 | 0.7 | 0.49–0.98 | 22 | 0.56 | 0.32–0.98 | |
Quartile 3 | 22.5–24.37 | 149 | 133 | 0.91 | 0.66–1.27 | 26 | 0.65 | 0.38–1.11 | |
Quartile 4 | >24.37 | 150 | 162 | 1.1 | 0.80–1.52 | 34 | 0.84 | 0.50–1.39 | |
P-trend | 0.31 | 0.55 | |||||||
females | Quartile 1 | <=18.97 | 132 | 69 | 1 | Reference | 22 | 1 | Reference |
Quartile 2 | 18.98–20.39 | 137 | 88 | 1.22 | 0.82–1.83 | 27 | 1.17 | 0.63–2.16 | |
Quartile 3 | 20.4–22.33 | 126 | 112 | 1.74 | 1.18–2.58 | 30 | 1.45 | 0.79–2.66 | |
Quartile 4 | >22.33 | 132 | 125 | 1.9 | 1.29–2.79 | 38 | 1.81 | 1.01–3.25 | |
P-trend | 0.00025 | 0.029 | |||||||
P-interaction+ | 0.097 | 0.18 |
CLL/SLL |
DLBCL |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Variable, level | Cut point Value |
Controls | Cases | Odds Ratio* |
95% CI | Cases | Odds Ratio* |
95% CI | DF^ | p- value^ |
|
Recent Adult BMI (2 years prior to case diagnosis / control enrollment) | |||||||||||
<18.5 | 13 | 1 | 0.36 | 0.05–2.82 | 2 | 1.14 | 0.25–5.22 | ||||
18.5–24.9 | 353 | 83 | 1 | Reference | 49 | 1 | Reference | ||||
25.0–29.9 | 466 | 127 | 1.05 | 0.76–1.43 | 69 | 1.03 | 0.69–1.53 | ||||
30.0+ | 286 | 87 | 1.19 | 0.85–1.68 | 55 | 1.35 | 0.89–2.04 | ||||
P-trend | 0.22 | 0.18 | 3 | 0.71 | |||||||
males | 18.5–24.9 | 118 | 39 | 1 | Reference | 16 | 1 | Reference | |||
25.0–29.9 | 302 | 89 | 0.9 | 0.58–1.39 | 42 | 1.02 | 0.55–1.88 | ||||
30.0+ | 174 | 62 | 1.08 | 0.68–1.72 | 33 | 1.39 | 0.73–2.64 | ||||
P-trend | 0.66 | 0.25 | 3 | 0.62 | |||||||
females | <18.5 | 13 | 1 | 0.41 | 0.05–3.20 | 2 | 1.1 | 0.24–5.11 | |||
18.5–24.9 | 235 | 44 | 1 | Reference | 33 | 1 | Reference | ||||
25.0–29.9 | 164 | 38 | 1.19 | 0.73–1.92 | 27 | 1.12 | 0.65–1.94 | ||||
30.0+ | 112 | 25 | 1.17 | 0.68–2.02 | 22 | 1.38 | 0.76–2.47 | ||||
P-trend | 0.35 | 0.32 | 3 | 0.95 | |||||||
P-interaction+ | 0.63 | 0.94 | |||||||||
Early Adult BMI (at age 18) | |||||||||||
Quartile 1 | 289 | 70 | 1 | Reference | 35 | 1 | Reference | ||||
Quartile 2 |
Uses gender specific cut- points below |
282 | 54 | 0.77 | 0.52–1.14 | 34 | 0.99 | 0.60–1.64 | |||
Quartile 3 | 275 | 86 | 1.29 | 0.90–1.84 | 47 | 1.43 | 0.89–2.28 | ||||
Quartile 4 | 282 | 87 | 1.27 | 0.89–1.82 | 60 | 1.77 | 1.13–2.77 | ||||
P-trend | 0.04 | 0.0040 | 3 | 0.47 | |||||||
males | Quartile 1 | <=20.94 | 157 | 49 | 1 | Reference | 22 | 1 | Reference | ||
Quartile 2 | 20.95–22.49 | 145 | 29 | 0.58 | 0.34–0.97 | 15 | 0.74 | 0.37–1.49 | |||
Quartile 3 | 22.5–24.37 | 149 | 53 | 1.05 | 0.67–1.65 | 21 | 1.01 | 0.53–1.92 | |||
Quartile 4 | >24.37 | 150 | 57 | 1.11 | 0.71–1.74 | 33 | 1.57 | 0.87–2.83 | |||
P-trend | 0.26 | 0.078 | 3 | 0.28 | |||||||
females | Quartile 1 | <=18.97 | 132 | 21 | 1 | Reference | 13 | 1 | Reference | ||
Quartile 2 | 18.98–20.39 | 137 | 25 | 1.18 | 0.63–2.22 | 19 | 1.39 | 0.66–2.94 | |||
Quartile 3 | 20.4–22.33 | 126 | 33 | 1.78 | 0.97–3.25 | 26 | 2.11 | 1.04–4.31 | |||
Quartile 4 | >22.33 | 132 | 30 | 1.52 | 0.82–2.80 | 27 | 2.16 | 1.06–4.38 | |||
P-trend | 0.093 | 0.017 | 3 | 0.72 | |||||||
P-interaction+ | 0.48 | 0.4 |
All models adjusted for age at enrollment, gender, and county of residence.
DF for the test of heterogeneity across the subtypes; note that these associated p-values are testing whether the trend differs across the three main subtypes and "other" subtypes.
p-value for the test of statistical interaction between gender and physical activity.